Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Biochimica Et Biophysica Acta
|
November 11, 1992
Mevinolin, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, suppresses enterocyte esterification of exogenous but not endogenous cholesterol
K Fellermann, F M Reimann, G Herold, et al.
Zeitschrift Fur Gastroenterologie
|
April 20, 2004
[The role of defensins in the pathogenesis of chronic-inflammatory bowel disease]
M Schmid, K Fellermann, J Wehkamp, et al.
The American Journal of Gastroenterology
|
October 15, 1998
Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506)
K Fellermann, D Ludwig, M Stahl, et al.
Zeitschrift Fur Gastroenterologie
|
April 5, 2016
Comorbidity in acute pancreatitis relates to organ failure but not to local complications
G Weitz, J Woitalla, P Wellhöner, et al.
European Journal of Gastroenterology & Hepatology
|
February 12, 1998
Crohn's disease and sarcoidosis: systemic granulomatosis?
K Fellermann, M Stahl, K Dahlhoff, et al.
Clinical and Experimental Immunology
|
January 15, 2008
Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2
M Schlee, J Harder, B Köten, et al.
Digestive Diseases and Sciences
|
July 29, 2005
Enhanced human beta-defensin-2 (hBD-2) expression by corticosteroids is independent of NF-kappaB in colonic epithelial cells (CaCo2)
T Witthöft, C S Pilz, K Fellermann, et al.
Digestion
|
January 1, 1992
Regulation of cholesterol metabolism and low-density lipoprotein binding in human intestinal Caco-2 cells
F M Reimann, G Herold, I Grosshans, et al.
Clinical and Experimental Immunology
|
April 12, 2013
Inflammatory bowel diseases influence major histocompatibility complex class I (MHC I) and II compartments in intestinal epithelial cells
F Bär, C Sina, G Hundorfean, et al.
Alimentary Pharmacology & Therapeutics
|
February 24, 2001
Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use
K R Herrlinger, M K Noftz, K Fellermann, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Biochimica Et Biophysica Acta
|
November 11, 1992
Mevinolin, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, suppresses enterocyte esterification of exogenous but not endogenous cholesterol
K Fellermann, F M Reimann, G Herold, et al.
Zeitschrift Fur Gastroenterologie
|
April 20, 2004
[The role of defensins in the pathogenesis of chronic-inflammatory bowel disease]
M Schmid, K Fellermann, J Wehkamp, et al.
The American Journal of Gastroenterology
|
October 15, 1998
Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506)
K Fellermann, D Ludwig, M Stahl, et al.
Zeitschrift Fur Gastroenterologie
|
April 5, 2016
Comorbidity in acute pancreatitis relates to organ failure but not to local complications
G Weitz, J Woitalla, P Wellhöner, et al.
European Journal of Gastroenterology & Hepatology
|
February 12, 1998
Crohn's disease and sarcoidosis: systemic granulomatosis?
K Fellermann, M Stahl, K Dahlhoff, et al.
Clinical and Experimental Immunology
|
January 15, 2008
Probiotic lactobacilli and VSL#3 induce enterocyte beta-defensin 2
M Schlee, J Harder, B Köten, et al.
Digestive Diseases and Sciences
|
July 29, 2005
Enhanced human beta-defensin-2 (hBD-2) expression by corticosteroids is independent of NF-kappaB in colonic epithelial cells (CaCo2)
T Witthöft, C S Pilz, K Fellermann, et al.
Digestion
|
January 1, 1992
Regulation of cholesterol metabolism and low-density lipoprotein binding in human intestinal Caco-2 cells
F M Reimann, G Herold, I Grosshans, et al.
Clinical and Experimental Immunology
|
April 12, 2013
Inflammatory bowel diseases influence major histocompatibility complex class I (MHC I) and II compartments in intestinal epithelial cells
F Bär, C Sina, G Hundorfean, et al.
Alimentary Pharmacology & Therapeutics
|
February 24, 2001
Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use
K R Herrlinger, M K Noftz, K Fellermann, et al.
Page
of 5